This includes pharmacokinetic and pharmacodynamic (PK/PD), physiologically based pharmacokinetic (PBPK), and quantitative systems pharmacology (QSP) models. Pumas can also perform non-compartmental analysis (NCA), bioequivalence and in vitro-in vivo correlation (IVIVC) analysis providing a common toolset to perform all analyses in the horizontal of clinical drug development and clinical trial simulation. Pumas is the first platform to provide true integration of pharmacometric models with convolution neural networks and other machine learning approaches. Pumas is massively scalable with an inherent ability to run on GPUs and on any hosted or private cloud computing setups in conjunction with JuliaTeam and JuliaRun. Pumas is a product from Pumas-AI, Inc.